Nevertheless, the treatment outcomes for advanced SDH‐deficient GIST patients are significantly worse than those for KIT‐mutant GIST patients, highlighting the need for more effective treatment strategies. This evidence concerns the gene SDHB and gastrointestinal stromal tumor.